Literature DB >> 21883099

Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis.

S Dragt1, D H Nieman, F Schultze-Lutter, F van der Meer, H Becker, L de Haan, P M Dingemans, M Birchwood, P Patterson, R K R Salokangas, M Heinimaa, A Heinz, G Juckel, H Graf von Reventlow, P French, H Stevens, S Ruhrmann, J Klosterkötter, D H Linszen.   

Abstract

OBJECTIVE: Numerous studies have found a robust association between cannabis use and the onset of psychosis. Nevertheless, the relationship between cannabis use and the onset of early (or, in retrospect, prodromal) symptoms of psychosis remains unclear. The study focused on investigating the relationship between cannabis use and early and high-risk symptoms in subjects at clinical high risk for psychosis.
METHOD: Prospective multicenter, naturalistic field study with an 18-month follow-up period in 245 help-seeking individuals clinically at high risk. The Composite International Diagnostic Interview was used to assess their cannabis use. Age at onset of high risk or certain early symptoms was assessed retrospectively with the Interview for the Retrospective Assessment of the Onset of Schizophrenia.
RESULTS: Younger age at onset of cannabis use or a cannabis use disorder was significantly related to younger age at onset of six symptoms (0.33 < r(s) < 0.83, 0.004 < P < 0.001). Onset of cannabis use preceded symptoms in most participants.
CONCLUSION: Our results provide support that cannabis use plays an important role in the development of psychosis in vulnerable individuals. Cannabis use in early adolescence should be discouraged.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21883099     DOI: 10.1111/j.1600-0447.2011.01763.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  21 in total

Review 1.  Approach to cannabis use disorder in primary care: focus on youth and other high-risk users.

Authors:  Suzanne D Turner; Sheryl Spithoff; Meldon Kahan
Journal:  Can Fam Physician       Date:  2014-09       Impact factor: 3.275

Review 2.  Medical and recreational marijuana: commentary and review of the literature.

Authors:  Samuel T Wilkinson
Journal:  Mo Med       Date:  2013 Nov-Dec

3.  Neurophysiologic effect of GWAS derived schizophrenia and bipolar risk variants.

Authors:  Mei-Hua Hall; Deborah L Levy; Dean F Salisbury; Steve Haddad; Patience Gallagher; Mary Lohan; Bruce Cohen; Dost Ongür; Jordan W Smoller
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2013-11-08       Impact factor: 3.568

Review 4.  Cannabis use in individuals at clinical high-risk for psychosis: a comprehensive review.

Authors:  Megan S Farris; Mohammed K Shakeel; Jean Addington
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-12-03       Impact factor: 4.328

Review 5.  Prescribing smoked cannabis for chronic noncancer pain: preliminary recommendations.

Authors:  Meldon Kahan; Anita Srivastava; Sheryl Spithoff; Lisa Bromley
Journal:  Can Fam Physician       Date:  2014-12       Impact factor: 3.275

6.  Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample.

Authors:  A M Auther; K S Cadenhead; R E Carrión; J Addington; C E Bearden; T D Cannon; T H McGlashan; D O Perkins; L Seidman; M Tsuang; E F Walker; S W Woods; B A Cornblatt
Journal:  Acta Psychiatr Scand       Date:  2015-01-09       Impact factor: 6.392

7.  Impact of Cannabis Use on the Development of Psychotic Disorders.

Authors:  Samuel T Wilkinson; Rajiv Radhakrishnan; Deepak Cyril D'Souza
Journal:  Curr Addict Rep       Date:  2014-06-01

8.  Predictors of a clinical high risk status among individuals with a family history of psychosis.

Authors:  Jacqueline Stowkowy; Jean Addington
Journal:  Schizophr Res       Date:  2013-04-20       Impact factor: 4.939

Review 9.  Marijuana: respiratory tract effects.

Authors:  Kelly P Owen; Mark E Sutter; Timothy E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

Review 10.  Substance use in clinical high risk for psychosis: a review of the literature.

Authors:  Jean Addington; Nevicia Case; Majid M Saleem; Andrea M Auther; Barbara A Cornblatt; Kristin S Cadenhead
Journal:  Early Interv Psychiatry       Date:  2013-11-14       Impact factor: 2.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.